<description>&lt;p&gt;In this episode, Ron Belldegrun, co-founder of ByHeart, shares how he raised over $300 million to transform the infant formula industry with cutting-edge science and a vertically integrated supply chain. Ron dives into his experience navigating the fundraising landscape, balancing the expectations of consumer and life science investors, and winning support for a mission-driven product in a highly regulated space. He talks candidly about the challenges of pitching a long-term vision, securing buy-in from top investors, and the critical role his existing investors played in scaling ByHeart’s groundbreaking approach. If you’re curious about how to raise significant capital while staying true to your mission and values, this is a must-listen.&lt;/p&gt;
</description>

<p>In this episode, Ron Belldegrun, co-founder of ByHeart, shares how he raised over $300 million to transform the infant formula industry with cutting-edge science and a vertically integrated supply chain. Ron dives into his experience navigating the fundraising landscape, balancing the expectations of consumer and life science investors, and winning support for a mission-driven product in a highly regulated space. He talks candidly about the challenges of pitching a long-term vision, securing buy-in from top investors, and the critical role his existing investors played in scaling ByHeart’s groundbreaking approach. If you’re curious about how to raise significant capital while staying true to your mission and values, this is a must-listen.</p>


Funded | How They Raised Millions

How Ron Belldegrun Closed a $95M Series C for ByHeart (Ron Belldegrun / ByHeart - Ep 52)

How Ron Belldegrun Closed a $95M Series C for ByHeart (Ron Belldegrun / ByHeart - Ep 52)

Description